Michael D. Berquist

Assistant Professor

UAMS

Also affiliated: Western Michigan University (2014–2019); Northern Michigan University (2013–2015); University of Arkansas Medical Center (2024); South College (2026)

11 h-index 43 pubs 383 cited

Research Areas

Biomedical Subjects

Links

ORCID Lab Website UAMS TRI Profile

OverviewAI-generated summary

Michael D. Berquist's research focuses on the neurobiological and behavioral effects of psychoactive substances, particularly stimulants and synthetic cannabinoids. His work investigates the dose-response relationships and pharmacokinetic profiles of compounds such as methamphetamine, 4-methylmethcathinone (4-MMC), and 3,4-methylenedioxypyrovalerone (MDPV) in rodent models. Berquist has published studies examining the pro-psychotic effects of synthetic cannabinoids and their interactions with central neurotransmitter systems. He has also characterized novel CB1 agonists for potential drug development and explored the cardiovascular effects of MDPV. His research has been conducted in collaboration with Lisa K. Brents, Brian J. Parks, and Julia Tobacyk, among others at the University of Arkansas for Medical Sciences. Berquist has authored 42 publications with 382 citations and an h-index of 11.

Metrics

h-index: 11
Publications: 43
Citations: 383

Positions

Assistant Professor publications 2017–2026

University of Arkansas for Medical Sciences Institution web page

Selected Publications

Interoceptive effects of N1-substituted lysergamides in rats: Role of agonist affinity at 5-hydroxytryptamine receptors and in vivo metabolism to lysergic acid diethylamide (2026)

Journal of Pharmacology and Experimental Therapeutics DOI OpenAlex
Comparison between a chimeric anti-methamphetamine monoclonal antibody and humanized antibodies on pharmacological effects of methamphetamine (2025)

Psychopharmacology DOI OpenAlex
Identifying a Lead Candidate Anti-methamphetamine Monoclonal Antibody for IND-enabling Studies: Cross-reactivity and Locomotor Activity (2024)

Journal of Pharmacology and Experimental Therapeutics DOI OpenAlex
Limited bedding and nesting increases ethanol drinking in female rats (2024)

Pharmacology Biochemistry and Behavior 10 citations DOI OpenAlex
Interaction between buprenorphine and norbuprenorphine in neonatal opioid withdrawal syndrome (2023)

Drug and Alcohol Dependence 3 citations DOI OpenAlex
Effects of a two-hit model of early life adversity on oral ethanol self-administration and adrenergic receptor expression in adolescent rats (2023)

Journal of Pharmacology and Experimental Therapeutics DOI OpenAlex
481 Interactions between buprenorphine and norbuprenorphine in neonatal opioid withdrawal syndrome (2023)

Journal of Clinical and Translational Science DOI OpenAlex
Interaction between buprenorphine and norbuprenorphine in neonatal opioid withdrawal syndrome. (2022)

bioRxiv (Cold Spring Harbor Laboratory) DOI OpenAlex
Effects of chronic and binge ethanol administration on mouse cerebellar and hippocampal neuroinflammation (2022)

The American Journal of Drug and Alcohol Abuse 16 citations DOI OpenAlex
Methamphetamine‐Induced Proteomic Changes Within the Neuroinflammatory TLR4 Pathway Persist After Long‐Term Self‐Administration in Rats (2022)

The FASEB Journal DOI OpenAlex
Effects of prenatal opioid exposure and early life adversity on opioid‐induced antinociception (2022)

The FASEB Journal DOI OpenAlex
Effects of 5-HT2A receptor agonist 2,5-dimethoxy-4-iodoamphetamine on alcohol consumption in Long–Evans rats (2021)

Behavioural Pharmacology 24 citations DOI OpenAlex
Methamphetamine-Induced Open Field Behavior and LD50 inPeriplaneta americanaCockroaches (Blattodea: Blattidae) (2020)

Journal of Economic Entomology 2 citations DOI OpenAlex
Effect of bile duct ligation-induced liver dysfunction on methamphetamine pharmacokinetics in male and female rats (2020)

Drug and Alcohol Dependence 4 citations DOI OpenAlex
Liver dysfunction effects on methamphetamine pharmacokinetics in male and female rats (2020)

Proceedings of the West Virginia Academy of Science DOI OpenAlex

View all publications on OpenAlex →

Grants & Funding

As listed on this researcher's institutional profile.

IND-enabling studies of a long-acting anti-methamphetamine monoclonal antibody for treating methamphetamine use disorder NIH/Nat. Inst. on Drug Abuse via InterveXion Therapeutics, LLC